Hyperfine, Inc.

that they have a little bit more run time before we start feeling really confident in how they're predicting quarters to come. There was not anything there that was one time. You know, we have those two orders that we continue to deliver a little bit every quarter, and that just continued on the same pattern. So it was strong from the U.S. It had a little bit of contribution from international, a little bit of contribution from Gates. I just want to make sure that we give our new leadership and sales professionals a little bit more runtime until we can be more confident about where we're going to land the plane at the end of the year.

That's fair. And a couple of follow-ups. One, the action PMR trial. How long do you think that'll take to enroll? What's the follow-up there? How long before we potentially see data?

Okay. It's a little hard to predict. We're doing this as we continue to also improve what I would call our offering on the stroke side. So our first order of business with that evaluation is to make sure that our latest software, which is going to be one more than the one that is commercially available, is able to detect as clinicians want the stroke in the acute settings. We have to do a little bit more work to shorten the time that it takes to gather those sequences. So we need to shorten the length of the sequences. So we will be continued on that development work and want to actually include faster sequences at some point in time also in the action PMR. There really is no follow-up to the study. All of it is really in the acute setting, the ability to really detect stroke and be able to get to a clinical decision about what is best for that patient in this evaluation. So no time to wait for follow-up data. but I want to be a little bit prudent that our enrollment may take a little longer as I want to make sure that we have the opportunity to put in the study the latest software, which is now embedded testing, but also faster sequences, which are currently in development and available later in the year.